Clinical Trial Update: Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial assessed guanfacine extended-release as an adjunct to stimulant therapy for improving executive function in children with ADHD; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• GXR (guanfacine extended-release) (guanfacine)

Snippet

Sponsor: JPM van Stralen Medicine Professional | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-05-23